These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27086111)

  • 21. In vitro ADMET and physicochemical investigations of poly-N-methylated peptides designed to inhibit Abeta aggregation.
    Bose PP; Chatterjee U; Hubatsch I; Artursson P; Govender T; Kruger HG; Bergh M; Johansson J; Arvidsson PI
    Bioorg Med Chem; 2010 Aug; 18(16):5896-902. PubMed ID: 20659803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vitro Metabolic Stability and Permeability of Gymnemagenin and Its In Vivo Pharmacokinetic Correlation in Rats - A Pilot Study.
    Bera R; Kundu A; Sen T; Adhikari D; Karmakar S
    Planta Med; 2016 Apr; 82(6):544-50. PubMed ID: 26916641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease.
    Scannevin RH; Chollate S; Brennan MS; Snodgrass-Belt PA; Peng H; Xu L; Jung MY; Bussiere T; Arastu MF; Talreja T; Xin Z; Dunstan RW; Fahrer D; Rohde E; Dunah AW; Wang J; Kumaravel G; Taveras AG; Moore Arnold H; Rhodes KJ
    Neuropharmacology; 2016 Apr; 103():57-68. PubMed ID: 26690893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that a synthetic amyloid-ß oligomer-binding peptide (ABP) targets amyloid-ß deposits in transgenic mouse brain and human Alzheimer's disease brain.
    Chakravarthy B; Ito S; Atkinson T; Gaudet C; Ménard M; Brown L; Whitfield J
    Biochem Biophys Res Commun; 2014 Mar; 445(3):656-60. PubMed ID: 24569075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease.
    Kawahara K; Suenobu M; Ohtsuka H; Kuniyasu A; Sugimoto Y; Nakagomi M; Fukasawa H; Shudo K; Nakayama H
    J Alzheimers Dis; 2014; 42(2):587-605. PubMed ID: 24916544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significant differences in the disposition of cyclic prodrugs of opioid peptides in rats and guinea pigs following IV administration.
    Liederer BM; Phan KT; Ouyang H; Borchardt RT
    J Pharm Sci; 2005 Dec; 94(12):2676-87. PubMed ID: 16258984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1.
    Egorin MJ; Zuhowski EG; Rosen DM; Sentz DL; Covey JM; Eiseman JL
    Cancer Chemother Pharmacol; 2001 Apr; 47(4):291-302. PubMed ID: 11345645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic and pharmacokinetic characterizations of an anti-amyloidogenic bis-styrylbenzene derivative for Alzheimer's disease treatment.
    Byeon SR; Kim HV; Jeon M; Ahn YG; Kim MS; Kong JY; Kim HY; Kim YS; Kim DJ
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3467-9. PubMed ID: 23601707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of the natural antibiotic negamycin.
    Guo J; Miele EW; Chen A; Luzietti RA; Zambrowski M; Walsky RL; Buurman ET
    Xenobiotica; 2015; 45(7):625-33. PubMed ID: 25733027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease.
    Miller DL; Papayannopoulos IA; Styles J; Bobin SA; Lin YY; Biemann K; Iqbal K
    Arch Biochem Biophys; 1993 Feb; 301(1):41-52. PubMed ID: 8442665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enantiomeric and diastereoisomeric (mixed) L/ D-octaarginine derivatives - a simple way of modulating the properties of cell-penetrating peptides.
    Purkayastha N; Eyer K; Robinson T; Dittrich PS; Beck AK; Seebach D; Kolesinska B; Cadalbert R
    Chem Biodivers; 2013 Jul; 10(7):1165-84. PubMed ID: 23847063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mirror image pairs of cyclic hexapeptides have different oral bioavailabilities and metabolic stabilities.
    Lohman RJ; Nielsen DS; Kok WM; Hoang HN; Hill TA; Fairlie DP
    Chem Commun (Camb); 2019 Nov; 55(89):13362-13365. PubMed ID: 31631195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D-Peptides as Recognition Molecules and Therapeutic Agents.
    Liu M; Li X; Xie Z; Xie C; Zhan C; Hu X; Shen Q; Wei X; Su B; Wang J; Lu W
    Chem Rec; 2016 Aug; 16(4):1772-86. PubMed ID: 27255896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
    Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
    J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic clearance and brain distribution of carbazole-based cyanine compounds as Alzheimer's disease drug candidates.
    Zhou W; Hu X; Tam KY
    Sci Rep; 2017 Nov; 7(1):16368. PubMed ID: 29180684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioavailability and kinetics of the antihypertensive casein-derived peptide HLPLP in rats.
    Sánchez-Rivera L; Ares I; Miralles B; Gómez-Ruiz JÁ; Recio I; Martínez-Larrañaga MR; Anadón A; Martínez MA
    J Agric Food Chem; 2014 Dec; 62(49):11869-75. PubMed ID: 25387326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection of D-amino-acid peptides that bind to Alzheimer's disease amyloid peptide abeta1-42 by mirror image phage display.
    Wiesehan K; Buder K; Linke RP; Patt S; Stoldt M; Unger E; Schmitt B; Bucci E; Willbold D
    Chembiochem; 2003 Aug; 4(8):748-53. PubMed ID: 12898626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid beta peptides with an additional cysteine residue can enhance immunogenicity and reduce the amyloid beta burden in an Alzheimer's disease mouse model.
    Matsuda J; Kaminaka K; Nozaki C
    Biochem Biophys Res Commun; 2009 Apr; 382(1):149-52. PubMed ID: 19265678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spirocyclic sulfamides as β-secretase 1 (BACE-1) inhibitors for the treatment of Alzheimer's disease: utilization of structure based drug design, WaterMap, and CNS penetration studies to identify centrally efficacious inhibitors.
    Brodney MA; Barreiro G; Ogilvie K; Hajos-Korcsok E; Murray J; Vajdos F; Ambroise C; Christoffersen C; Fisher K; Lanyon L; Liu J; Nolan CE; Withka JM; Borzilleri KA; Efremov I; Oborski CE; Varghese A; O'Neill BT
    J Med Chem; 2012 Nov; 55(21):9224-39. PubMed ID: 22984865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.